PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 5OVW

#CDRs = 4; #Clusters = 4.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
G	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	76.9	H1	13	H1-13-*	-1	AAPESTLDDYAIG	BBBLBBAAABBBB
G	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	60.0	H2	10	H2-10-2	10	CIGSSGDSTN	BBBAALABBB
G	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	100.0	H3	20	H3-20-*	-1	AAAHRIfggclvIHSSGYVS
G	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	87.5	H4	8	H4-8-1	7	RDNAKNTV	BBAAALBB
H	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	76.9	H1	13	H1-13-*	-1	AAPESTLDDYAIG	BBBLBBAAABBBB
H	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	60.0	H2	10	H2-10-2	9	CIGSSGDSTN	BBBAALABBB
H	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	100.0	H3	20	H3-20-*	-1	AAAHRIfggclvIHSSGYVS
H	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	87.5	H4	8	H4-8-1	7	RDNAKNTV	BBAAALBB
I	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	76.9	H1	13	H1-13-*	-1	AAPESTLDDYAIG	BBBLBBAAABBBB
I	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	60.0	H2	10	H2-10-2	10	CIGSSGDSTN	BBBAALABBB
I	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	100.0	H3	20	H3-20-*	-1	AAAHRIfggclvIHSSGYVS
I	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	87.5	H4	8	H4-8-1	7	RDNAKNTV	BBAAALBB
J	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	76.9	H1	13	H1-13-*	-1	AAPESTLDDYAIG	BBBLBBAAABBBB
J	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	60.0	H2	10	H2-10-2	10	CIGSSGDSTN	BBBAALABBB
J	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	100.0	H3	20	H3-20-*	-1	AAAHRIfggclvIHSSGYVS
J	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	87.5	H4	8	H4-8-1	7	RDNAKNTV	BBAAALBB
K	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	76.9	H1	13	H1-13-*	-1	AAPESTLDDYAIG	BBBLBBAAABBBB
K	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	60.0	H2	10	H2-10-2	10	CIGSSGDSTN	BBBAALABBB
K	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	100.0	H3	20	H3-20-*	-1	AAAHRIfggclvIHSSGYVS
K	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	87.5	H4	8	H4-8-1	7	RDNAKNTV	BBAAALBB
L	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	76.9	H1	13	H1-13-*	-1	AAPESTLDDYAIG	BBBLBBAAABBBB
L	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	60.0	H2	10	H2-10-2	10	CIGSSGDSTN	BBBAALABBB
L	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	100.0	H3	20	H3-20-*	-1	AAAHRIfggclvIHSSGYVS
L	heavy	Lama.glama	La_IGHV1S2*01_VHH	93.2	La_IGHV1S2*01_VHH	87.5	H4	8	H4-8-1	7	RDNAKNTV	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on July 15, 2024